S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Reasons this Tech Giant is Going Back to Highs
Options Trading Plan–Perfect For Beginners (Ad)
3 Compelling Reasons to Start Buying Undervalued Amazon
5 Reasons Why Amprius is About to Take Flight 
Options Trading Plan–Perfect For Beginners (Ad)
Stock market today: Asian shares mixed after interest rates-driven sell-off on Wall Street
Analysts Recommend These Mining Stocks Before Metal Prices Rally
Options Trading Plan–Perfect For Beginners (Ad)
5 Sizzling Tech Companies on the Brink of Bullish Reversals
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Reasons this Tech Giant is Going Back to Highs
Options Trading Plan–Perfect For Beginners (Ad)
3 Compelling Reasons to Start Buying Undervalued Amazon
5 Reasons Why Amprius is About to Take Flight 
Options Trading Plan–Perfect For Beginners (Ad)
Stock market today: Asian shares mixed after interest rates-driven sell-off on Wall Street
Analysts Recommend These Mining Stocks Before Metal Prices Rally
Options Trading Plan–Perfect For Beginners (Ad)
5 Sizzling Tech Companies on the Brink of Bullish Reversals
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Reasons this Tech Giant is Going Back to Highs
Options Trading Plan–Perfect For Beginners (Ad)
3 Compelling Reasons to Start Buying Undervalued Amazon
5 Reasons Why Amprius is About to Take Flight 
Options Trading Plan–Perfect For Beginners (Ad)
Stock market today: Asian shares mixed after interest rates-driven sell-off on Wall Street
Analysts Recommend These Mining Stocks Before Metal Prices Rally
Options Trading Plan–Perfect For Beginners (Ad)
5 Sizzling Tech Companies on the Brink of Bullish Reversals
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Reasons this Tech Giant is Going Back to Highs
Options Trading Plan–Perfect For Beginners (Ad)
3 Compelling Reasons to Start Buying Undervalued Amazon
5 Reasons Why Amprius is About to Take Flight 
Options Trading Plan–Perfect For Beginners (Ad)
Stock market today: Asian shares mixed after interest rates-driven sell-off on Wall Street
Analysts Recommend These Mining Stocks Before Metal Prices Rally
Options Trading Plan–Perfect For Beginners (Ad)
5 Sizzling Tech Companies on the Brink of Bullish Reversals
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
NASDAQ:ACHV

Achieve Life Sciences (ACHV) Stock Forecast, Price & News

$4.40
-0.01 (-0.23%)
(As of 09/21/2023 ET)
Compare
Today's Range
$4.35
$4.47
50-Day Range
$4.40
$5.68
52-Week Range
$2.00
$10.30
Volume
37,157 shs
Average Volume
46,763 shs
Market Capitalization
$92.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.67

Achieve Life Sciences MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
324.2% Upside
$18.67 Price Target
Short Interest
Bearish
3.41% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.33mentions of Achieve Life Sciences in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.62) to ($1.61) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.83 out of 5 stars

Medical Sector

746th out of 965 stocks

Diagnostic Substances Industry

10th out of 13 stocks


ACHV stock logo

About Achieve Life Sciences (NASDAQ:ACHV) Stock

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.

ACHV Price History

ACHV Stock News Headlines

The Achieve Foundation Newstead 5K is Saturday, September 30
Better Than Oil Stocks?
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment.
ACHV: 2Q:23 Results
Q2 2023 Achieve Life Sciences Inc Earnings Call
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
ACHV - Achieve Life Sciences, Inc.
ACHV: ORCA-3 Topline
See More Headlines
Receive ACHV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Achieve Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

ACHV Company Calendar

Last Earnings
8/14/2023
Today
9/21/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
Biotechnology
Sector
Medical
Current Symbol
NASDAQ:ACHV
CUSIP
68230A10
Employees
20
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$18.67
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$17.00
Forecasted Upside/Downside
+324.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-42,350,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.46 per share

Miscellaneous

Free Float
20,684,000
Market Cap
$92.87 million
Optionable
Not Optionable
Beta
1.52
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. Richard A. B. Stewart (Age 64)
    Exec. Chairman
    Comp: $575k
  • Mr. John A. Bencich M.B.A. (Age 46)
    CEO & Director
    Comp: $733.12k
  • Dr. Cindy Jacobs M.D. (Age 65)
    Ph.D., Pres, Chief Medical Officer & Director
    Comp: $614.25k
  • Mr. Jerry Wan (Age 41)
    Principal Accounting Officer
  • Dr. Anthony Clarke (Age 67)
    Chief Scientific Officer
  • Ms. Jaime Xinos
    Exec. VP of Commercial













ACHV Stock - Frequently Asked Questions

Should I buy or sell Achieve Life Sciences stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Achieve Life Sciences in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ACHV shares.
View ACHV analyst ratings
or view top-rated stocks.

What is Achieve Life Sciences' stock price forecast for 2023?

2 equities research analysts have issued twelve-month price objectives for Achieve Life Sciences' shares. Their ACHV share price forecasts range from $17.00 to $20.00. On average, they expect the company's share price to reach $18.67 in the next twelve months. This suggests a possible upside of 324.2% from the stock's current price.
View analysts price targets for ACHV
or view top-rated stocks among Wall Street analysts.

How have ACHV shares performed in 2023?

Achieve Life Sciences' stock was trading at $2.45 at the beginning of the year. Since then, ACHV shares have increased by 79.6% and is now trading at $4.40.
View the best growth stocks for 2023 here
.

When is Achieve Life Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our ACHV earnings forecast
.

How were Achieve Life Sciences' earnings last quarter?

Achieve Life Sciences, Inc. (NASDAQ:ACHV) announced its earnings results on Monday, August, 14th. The biopharmaceutical company reported ($0.43) earnings per share for the quarter, missing analysts' consensus estimates of ($0.41) by $0.02.

When did Achieve Life Sciences' stock split?

Achieve Life Sciences's stock reverse split on the morning of Friday, July 31st 2020. The 1-20 reverse split was announced on Thursday, July 30th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, July 30th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Achieve Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Achieve Life Sciences investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Gran Tierra Energy (GTE), Bionano Genomics (BNGO), Novan (NOVN), Aeterna Zentaris (AEZS), Zosano Pharma (ZSAN), CNBX Pharmaceuticals (CNBX), KushCo (KSHB) and Pennsylvania Real Estate Investment Trust (PEI).

What is Achieve Life Sciences' stock symbol?

Achieve Life Sciences trades on the NASDAQ under the ticker symbol "ACHV."

Who are Achieve Life Sciences' major shareholders?

Achieve Life Sciences' stock is owned by many different institutional and retail investors. Top institutional shareholders include Shay Capital LLC (4.30%), AWM Investment Company Inc. (1.51%), B. Riley Wealth Advisors Inc. (1.20%), Geode Capital Management LLC (0.90%), LPL Financial LLC (0.82%) and Raymond James & Associates (0.76%).
View institutional ownership trends
.

How do I buy shares of Achieve Life Sciences?

Shares of ACHV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Achieve Life Sciences' stock price today?

One share of ACHV stock can currently be purchased for approximately $4.40.

How much money does Achieve Life Sciences make?

Achieve Life Sciences (NASDAQ:ACHV) has a market capitalization of $92.87 million. The biopharmaceutical company earns $-42,350,000.00 in net income (profit) each year or ($3.11) on an earnings per share basis.

How can I contact Achieve Life Sciences?

Achieve Life Sciences' mailing address is 1040 WEST GEORGIA STREET SUITE 1030, VANCOUVER BC, V6E 4H1. The official website for the company is achievelifesciences.com. The biopharmaceutical company can be reached via phone at (604) 210-2217, via email at jwong@bplifescience.com, or via fax at 425-686-1600.

This page (NASDAQ:ACHV) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -